Back

Temporal Transcriptomics Identifies Isoform-specific Trans-regulation by Multiple lncRNAs in Human iPSCs

Liu, M.; Mamede, I.; Sofi, S.; Pereira, I.; Dostal, V.; Pashos, A. R. S.; McMahon, C.; Waikar, A.; Stephenson, G.; Cech, T. R.; Rinn, J. L.

2026-05-14 genomics
10.64898/2026.05.13.724994 bioRxiv
Show abstract

Some long non-coding RNAs (lncRNAs) are known to regulate gene expression. However, the underlying temporal dynamics of lncRNAs influencing gene and epigenetic regulation and mechanisms of lncRNA regulation in trans are less understood. To investigate this, we genetically engineered 17 doxycycline-inducible lncRNA transgenes for ectopic expression at the H11 safe harbor locus in human pluripotent stem cells (hiPSCs), and we generated high-density temporal RNA-seq and ATAC-seq profiles. Most lncRNA transgenes were induced at 2 hours and maintained expression through the 96-hour time course. Surprisingly, when we sought to identify gene expression changes due to the lncRNAs, we found that the global transcriptional landscape was dominated by a strong systemic response triggered by doxycycline exposure. We rigorously defined this cohort of genes as a Doxycycline-Responsive Gene Signature (DRGS). The DRGS was also present in at least 28 public datasets from dox-inducible transgene studies involving diverse cell types. Next, we determined which lncRNAs exhibited trans-regulatory events. We identified DANCR, FENDRR, LINC00667, LINC00847, LNCPRESS1, and PNKY as lncRNAs that regulate specific transcript expression in trans. The downstream target genes encoded 53 mRNAs and 10 lncRNAs. None of the target lncRNAs altered gene expression proximal to their own loci (i.e., triggering secondary cis-effects). Surprisingly, the target genes of LINC00847 (transcribed from chromosome 22) were substantially enriched on chromosome 19, with a preponderance of target genes encoding RNA metabolism and RNA splicing factors. Collectively, our study provides a resource to discern artifacts in the doxycycline-inducible system and identifies temporally regulated targets of 6 lncRNAs for future mechanistic studies.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Genome Research
409 papers in training set
Top 0.1%
18.6%
2
Nature Communications
4913 papers in training set
Top 25%
7.2%
3
Cell Reports
1338 papers in training set
Top 6%
6.8%
4
Cell Genomics
162 papers in training set
Top 0.4%
6.8%
5
iScience
1063 papers in training set
Top 1%
6.4%
6
Genome Biology
555 papers in training set
Top 1%
6.4%
50% of probability mass above
7
Scientific Reports
3102 papers in training set
Top 24%
4.9%
8
eLife
5422 papers in training set
Top 29%
3.1%
9
Nucleic Acids Research
1128 papers in training set
Top 8%
2.6%
10
Stem Cell Reports
118 papers in training set
Top 0.3%
2.6%
11
Genome Medicine
154 papers in training set
Top 3%
2.6%
12
Frontiers in Genetics
197 papers in training set
Top 4%
1.9%
13
BMC Genomics
328 papers in training set
Top 2%
1.9%
14
Cell Reports Methods
141 papers in training set
Top 2%
1.8%
15
Molecular Cell
308 papers in training set
Top 8%
1.2%
16
Nature Biotechnology
147 papers in training set
Top 6%
1.1%
17
Computational and Structural Biotechnology Journal
216 papers in training set
Top 7%
0.9%
18
Cell Systems
167 papers in training set
Top 10%
0.9%
19
Cell Chemical Biology
81 papers in training set
Top 3%
0.9%
20
PLOS ONE
4510 papers in training set
Top 64%
0.9%
21
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 5%
0.8%
22
RNA Biology
70 papers in training set
Top 0.4%
0.8%
23
The American Journal of Human Genetics
206 papers in training set
Top 4%
0.7%
24
PLOS Computational Biology
1633 papers in training set
Top 25%
0.7%
25
Human Molecular Genetics
130 papers in training set
Top 3%
0.7%
26
Science Advances
1098 papers in training set
Top 30%
0.7%
27
Development
440 papers in training set
Top 3%
0.7%
28
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 46%
0.7%
29
Protein & Cell
25 papers in training set
Top 3%
0.6%